Mariamena Arbitrio

Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?

Iole Cucinotto, Lucia Fiorillo, S Gualtieri et al. · Journal of Drug Delivery · 2013 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts

Maria Rita Pitari, Marco Rossi, Nicola Amodio et al. · Oncotarget · 2015 · 97 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study

Maria Teresa Di Martino, Mariamena Arbitrio, Emanuela Leone et al. · Cancer Biology & Therapy · 2011 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma

Maria Angelica Stamato, Giada Juli, Enrica Romeo et al. · Oncotarget · 2017 · 71 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study

Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio et al. · Journal of Hematology & Oncology · 2023 · 70 citations · Full text

Medicine, Oncology, Pharmacology +13